New Chalcone Incorporated Structurally Modified Pyridine-Pyrimidine Derivatives as Anticancer Agents: Their Design,...

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Cancer Research

Background:

• Chalcones and pyridine-pyrimidines are known pharmacophores with diverse biological activities.
• Developing novel anticancer agents is crucial for improving patient outcomes.

Purpose of the Study:

• To synthesize novel chalcone-incorporated pyridine-pyrimidine derivatives.
• To evaluate the in vitro anticancer potential of these synthesized compounds against various human cancer cell lines.

Main Methods:

• Synthesis of target compounds via established organic chemistry protocols.
• Structural confirmation using analytical techniques (e.g., NMR, Mass Spectrometry).
• Anticancer activity assessment using the MTT assay against MCF-7, DU-145, PC3, and A549 cell lines, with etoposide as a positive control.

Main Results:

• Successful synthesis and structural elucidation of chalcone-incorporated pyridine-pyrimidine derivatives.
• Compounds were evaluated for their inhibitory concentration 50 (IC50) values against selected cancer cell lines.
• IC50 values ranged from 1.97±0.45 μM to 3.08±0.135 μM, with compounds 10(a-e) exhibiting significant activity.

Conclusions:

• The synthesized chalcone-incorporated pyridine-pyrimidine derivatives demonstrate promising in vitro anticancer activity.
• Specific compounds showed notable efficacy against breast, prostate, and lung cancer cell lines.
• These findings suggest potential for further development as novel chemotherapeutic agents.